PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Activity

31 hedge funds and large institutions have $5.05M invested in Protalix BioTherapeutics in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 9 closing their positions.

Holders
31
Holders Change
-2
Holders Change %
-6.06%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
3
Closed
9
Calls
$46K
Puts
$142K
Net Calls
-$96K
Net Calls Change
+$86K

Top Buyers

1
OM
1
Opaleye Management
Massachusetts
$469K
2
JGC
2
J. Goldman & Co
New York
$235K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$2.03M
4
Group One Trading
4
Group One Trading
Illinois
$105K
5
WS
5
Wedbush Securities
California
$40K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
VanEck Associates
2
VanEck Associates
New York
$0
3
VF
3
Virtu Financial
New York
$9K
4
Simplex Trading
4
Simplex Trading
Illinois
$0
5
BRWM
5
B. Riley Wealth Management
Tennessee
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$5K – – –
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
– -$46K -10,382 Closed
VanEck Associates
28
VanEck Associates
New York
– -$34K -7,732 Closed
Simplex Trading
29
Simplex Trading
Illinois
– -$8K -2,030 Closed
BRWM
30
B. Riley Wealth Management
Tennessee
– -$8K -1,833 Closed
AA
31
Advisory Alpha
Michigan
– -$2K -500 Closed
KPW
32
Kore Private Wealth
New York
– -$2K -500 Closed
1
2